IHPS National Advisory Board

We are deeply honored to have the support and counsel of an outstanding group of national and international leading policy leaders on our advisory board.

Steven A. Schroeder, MD – Chair

Steven A. SchroederSteve Schroeder, MD is a Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine at UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers. It has expanded the types of clinician groups that support cessation, developed an alternative cessation message (Ask, Advise, Refer), created new ways to market toll-free telephone quit lines, and engaged the mental health and addictions treatment community for the first time. The Center's current work is focused especially on how to reduce the huge health burden from smoking that falls upon those with mental illnesses and/or substance abuse disorders. SCLC works collaboratively with SAMHSA, HRSA, the CDC, and multiple health professional groups to provide technical assistance to help strengthen smoking cessation capabilities. The Center has also facilitated summit meetings involving 18 states that conduct tobacco cessation summits enabling states to achieve targeted reductions in smoking rates among behavioral health populations. In 2018 it was designated by SAMHSA as the National Center for Excellence in Tobacco-Free Recovery.

Between 1990 and 2002, Dr. Schroeder was President and CEO of the Robert Wood Johnson Foundation. During that time the Foundation made grant expenditures of almost $4 billion in pursuit of its mission of improving the health and health care of all Americans. It developed new programs in substance abuse prevention and treatment, care at the end of life, and health insurance expansion for children, among others.

Dr. Schroeder graduated with honors from Stanford University and Harvard Medical School, and trained in internal medicine at the Harvard Medical Service of Boston City Hospital and in epidemiology as an EIS Officer of the CDC. He held faculty appointments at Harvard, George Washington, and UCSF. At both George Washington and UCSF, he was the founding medical director of a university-sponsored HMO, and at UCSF he founded its division of general internal medicine. He is a director of the Marin Community Foundation, and Mathematica Policy Research, former member of the editorial board of the New England Journal of Medicine (19 years) and former chair of the Health Care Services Board of the Institute of Medicine as well as a member of the IOM Council (now National Academy of Medicine). He chaired the American Legacy Foundation (now Truth Initiative), was an overseer of Harvard, president of the Harvard Medical Alumni Association, and director of the James Irvine Foundation. In 2014 he was named a public member of the Congressionally-mandated federal Interagency Committee on Smoking and Health. He has won numerous awards, including six honorary doctoral degrees and the Gustav O. Leinhard Award from the National Academy of Medicine. He and his wife Sally live in Tiburon, CA. They have two physician sons and four grandchildren.

Nancy E. AdlerNancy E. Adler, Ph.D.Nancy E. Adler, PhD is the Lisa and John Pritzker Professor of Psychology, in the Departments of Psychiatry and Pediatrics, Vice-Chair of the Department of Psychiatry, and Director of the Center for Health and Community. A Social Psychologist, she received her BA from Wellesley College and her Ph.D. from Harvard University.

Dr. Adler’s earlier research examined the utility of decision models for understanding health behaviors with a particular focus on reproductive health. This work identified determinants of consequences of unwanted pregnancy and infertility. As director of the MacArthur Foundation Research Network on SES and Health, she coordinated research spanning social, psychological and biological mechanisms by which SES influences health, and developed a widely used measure of subjective social status. She is currently working to expand the standard collection of information on social and behavioral determinants of health in electronic health records, and to document the impact of having this information on clinical care and health outcomes. For over 25 years Dr. Adler directed a T32 post-doctoral training program in “Psychology and Medicine: An Integrative Research Approach”, supported by NIMH. She also co-directed the UCSF-UC Berkeley site of the Robert Wood Johnson Health and Society Scholars Program.

Dr. Adler has served on various advisory committees, including the Advisory Committee to the Director of NIH, the Visiting Committee for the Harvard School of Public Health, and the Executive Committee of the Council of the National Academy of Medicine (NAM). She has been elected to membership in NAM and in the American Academy of Arts and Sciences (AAAS). She’s been awarded the Chancellor’s Award for Advancement of Women, George Sarlo Prize for Excellence in Teaching, Lifetime Achievement in Mentoring Award, and the Lloyd Holly Smith Award from UCSF; the James McKeen Cattell Award from the American Psychological Society (APS); Distinguished Scientific Award for the Application of Psychology from the American Psychological Association (APA); the Marion Spencer Fay Award from the Institute for Women’s Health Leadership; the David Rall Medal from the NAM/IOM; and the Medal for Distinguished Contributions to Biomedical Sciences from the New York Academy of Medicine.


Susan Dentzer is the Senior Policy Fellow for the Robert J. Margolis Center for Health Policy at Duke University. Based in Washington, DC, where the center’s research team is located, she focuses on health system transformation, biopharmaceutical policy, and other key health policy issues. Ms. Dentzer is one of the nation's most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio, including PBS and NPR, and an author of commentaries and analyses in print publications such as Modern Healthcare. She was also the editor and lead author of the book Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care, available on Amazon.com.

From March 2016 to February 2018, Ms. Dentzer was President and Chief Executive Officer of NEHI, the Network for Excellence in Health Innovation, a nonprofit, nonpartisan organization then composed of more than 80 stakeholder organizations from across all key sectors of health and health care. From 2013 to 2016, she was senior policy adviser to the Robert Wood Johnson Foundation, the nation’s largest philanthropy focused on health and health care in the United States, and before that, was the editor-in-chief of the policy journal Health Affairs. From 1998 to 2008, she was the on-air Health Correspondent for the PBS NewsHour. Ms. Dentzer wrote and hosted the 2015 PBS documentary, Reinventing American Healthcare, focusing on the innovations pioneered by the Geisinger Health System and spread to health systems across the nation.

Ms. Dentzer is an elected member of the National Academy of Medicine (formerly the Institute of Medicine) and also serves on the Board on Population Health and Public Health Practice of the National Academies of Science, Medicine, and Engineering. She is an elected member of the Council on Foreign Relations; a fellow of the National Academy of Social Insurance; and a fellow of the Hastings Center, a nonpartisan bioethics research institute. She is also a member of the Board of Directors of the International Rescue Committee, a leading global humanitarian organization; a member of the board of directors of Research!America, which advocates on behalf of biomedical and health-related research; and a member of the board of directors of the Public Health Institute, a nonprofit organization addressing public health issues and solutions nationwide. Ms. Dentzer serves on the global access public policy advisory committee for Roche, the international biopharmaceutical company based in Basel, Switzerland. She is a member of the Boards of Advisors for RAND Health and the Philip R. Lee Institute of Health Policy Studies at the University of California, San Francisco. From 2011 to 2017 she was public member of the Board of Directors of the American Board of Medical Specialties, which assists 24 medical specialty boards in the ongoing evaluation and certification of physicians.

Ms. Dentzer graduated from Dartmouth, is a trustee emerita of the college, and chaired the Dartmouth Board of Trustees from 2001 to 2004. She serves on the advisory board for the Center for Global Health Equity at Dartmouth, and previously was a member of the Board of Advisors of Dartmouth’s Geisel School of Medicine for more than two decades. Ms. Dentzer holds an honorary master’s degree from Dartmouth and an honorary doctorate in humane letters from Muskingum University. She and her husband have three adult children.

Jeffrey KangJeffrey Kang, MD, MPH, has over 35 years of progressive, health care experience in four major areas - primary care, commercial health insurance, retail healthcare, and government. First, for his primary care background, Dr. Kang is a geriatrician and has led successful, full-risk primary care practices for Pacificare/Secure Horizon, EverCare (a nursing home population), PACE (Program for All-inclusive Care for the Elderly – a home bound population) and, most recently, ChenMed, providing concierge level, primary care from low to moderate incomes, Medicare Advantage beneficiaries. Second, for his health insurance background, he was Chief Medical Officer for Cigna, responsible for the clinical policy for its medical, pharmacy and behavioral products and launching its medical home and accountable care initiatives. Third, for his retail healthcare background, Dr. Kang was SVP for Walgreens, responsible for its emerging health care businesses including retail clinics, worksite clinics, ACO’s, hospital pharmacies and PBM. Finally, and fourth, for his government background, he served as the very first Chief Clinical Officer for the Centers for Medicare and Medicaid Service (CMS), responsible for the agency’s quality measurement and improvement efforts, its healthcare regulations, and its coverage decisions for both Medicaid and Medicare.

Dr. Kang is currently the founding CEO of WellBe Senior Medical, an innovative health care platform providing concierge, team-based, geriatric care to the frail, poly-chronic, elderly Medicare Advantage beneficiary on a global capitated basis. In addition, he serves on the Board of Directors of the National Committee for Quality Assurance (NCQA), ChenMed, and Blue Cross/Blue Shield of Minnesota and on the Advisory Board of the Center for Health Incentives and Behavioral Economics (CHIBE).

ara RosenbaumSara Rosenbaum JD is the Harold and Jane Hirsh Professor of Health Law and Policy and Founding Chair of the Department of Health Policy at George Washington University’s Milken Institute School of Public Health. Professor Rosenbaum has devoted her career to health justice for medically underserved populations, emphasizing public engagement, along with academic and judicial scholarship, as core aspects of her work. Among her many public service activities, Professor Rosenbaum is a member of the National Academies of Sciences Engineering and Medicine and the National Academy of Social Insurance and is the incoming Board Chair of FAIRHealth, the nation’s largest source of health care cost and utilization information.

Professor Rosenbaum has also served on the CDC’s Director’s Advisory Committee and its Advisory Committee on Immunization Practice. She previously served as Board Chair of AcademyHealth and the National Academy for State Health Policy. Professor Rosenbaum was a founding Commissioner on Congress’s Medicaid and CHIP Payment and Access Commission (MACPAC), which she chaired from January 2016 through April 2017.

Bern ShenBern Shen, MD is Chief Medical Officer of HealthCrowd. Alongside important social, commercial and political determinants of health (and health policy), technology will likely play an increasing role in both informing and enabling optimal health and policy. Dr. Shen brings to the IHPS Advisory Board his experience as a researcher, forecaster, entrepreneur and investor, aiming to serve IHPS as a health/tech “radar” and reality check.

Originally double Board Certified in Internal Medicine and Emergency Medicine, Dr. Shen practiced clinically for fifteen years in both the US and abroad (with a focus on disaster medicine) before transitioning to a health tech career. He discovered an affinity for health/tech forecasting while working at Hewlett Packard Labs, Oracle, and as Intel’s chief healthcare strategist, and while leading the health practice at the Institute for the Future.

After a decade in large tech companies, he then spent a decade as a startup entrepreneur, advisor and investor (with the Band of Angels, Silicon Valley’s oldest angel group). During this time, he also served as a health/tech “oracle” to reinsurance and risk expert, Swiss Re, a founding Board member of Clayton Christensen’s Institute for Disruptive Innovation, and a tech transfer expert at the University of Iowa and the Cleveland Clinic.

Lisa SimpsonLisa Simpson, MB, BCh, MPH, FAAP has been the President and Chief Executive Officer of AcademyHealth since 2011. A nationally recognized health policy researcher and pediatrician, she is a passionate advocate for the translation of research into policy and practice. Her research, and over 90 articles and commentaries in peer-reviewed journals, focuses on the role of evidence and data to improve health and healthcare, particularly for children and vulnerable populations.

Before joining AcademyHealth, Dr. Simpson spent eight years as a professor of pediatrics, first as an Endowed Chair in Child Health Policy at the University of South Florida and then as the Director of the Child Policy Research Center at Cincinnati Children's Hospital Medical Center and the University of Cincinnati. She served as the Deputy Director of the Agency for Healthcare Research and Quality from 1996 to 2002. Dr. Simpson serves on the Robert Wood Johnson Health Policy Scholars Program National Advisory Council, the Board of Directors of the Institute for Accountable Care, and the Editorial Boards for the Journal of Comparative Effectiveness Research and Healthcare: The Journal of Delivery Science and Innovation. In October 2013, Dr. Simpson was elected to the National Academy of Medicine (formerly the Institute of Medicine).

Dr. Simpson earned her undergraduate and medical degrees at Trinity College (Dublin, Ireland), a master’s in public health at the University of Hawaii, and completed a post-doctoral fellowship in health services research and health policy at the University of California, San Francisco. She was awarded an honorary Doctor of Science degree by the Georgetown University School of Nursing and Health Studies in 2013.

Dr. Simpson's areas of expertise include translating research into policy; quality and safety of health care; health and health care disparities; childhood obesity; and child health services.